A multimodal treatment approach that included off-label emicizumab, a drug approved for hemophilia A, stopped severe, hard-to-treat gastrointestinal bleeding in a 72-year-old woman with acquired…
News
September is National ITP Awareness Month in the U.S., a time when advocates work to raise awareness and support research into immune thrombocytopenia (ITP).
HMB-002, an experimental antibody-based treatment from Hemab Therapeutics for von Willebrand disease (VWD), increased levels of von Willebrand factor (VWF) and improved measures…
Immune thrombocytopenia (ITP) can occur in people with antiphospholipid syndrome (APS), another immune disorder — and people who have co-occurring ITP and APS almost…
An Iranian woman with congenital thrombotic thrombocytopenic purpura (TTP) successfully delivered a healthy baby boy after receiving regular infusions of fresh frozen plasma and…
Many people with von Willebrand disease (VWD) may experience bleeding for years before being diagnosed, and some cases may still go unrecognized, according to…
In a clinical trial involving adults with hard-to-treat immune thrombocytopenia (ITP), adding a 12-week course of a vitamin A-derived compound called all-trans retinoic acid…
Starting plasma exchange — a procedure to replace a portion of a patient’s blood with that of a healthy donor — within one day of…
A three-week educational program delivered through WhatsApp may help mothers of children with immune thrombocytopenia (ITP) prevent Helicobacter pylori infection, a bacterial infection that…
Researchers in Turkey have uncovered changes in immune cells and surface proteins on platelets, which are tiny, colorless cell fragments in the blood that help…
